G1 Therapeutics, Inc. (GTHX)
Sep 18, 2024 - GTHX was delisted (acquired by Pharmacosmos)
7.15
0.00 (0.00%)
Inactive · Last trade price on Sep 17, 2024

G1 Therapeutics Revenue

G1 Therapeutics had revenue of $16.55M in the quarter ending June 30, 2024, a decrease of -60.97%. This brings the company's revenue in the last twelve months to $58.20M, down -34.73% year-over-year. In the year 2023, G1 Therapeutics had annual revenue of $82.51M with 60.84% growth.

Revenue (ttm)
$58.20M
Revenue Growth
-34.73%
P/S Ratio
6.40
Revenue / Employee
$581,950
Employees
100
Market Cap
378.17M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202382.51M31.21M60.84%
Dec 31, 202251.30M19.83M62.98%
Dec 31, 202131.48M-13.81M-30.49%
Dec 31, 202045.29M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro